Skip to main content
Quest Diagnostics Home

Hepatitis C: Implementing the New Guidelines During the Pandemic

Date: Tuesday, Sep 1, 2020

Description: Dr. William J. Becker along with Dr. Weston Rothrock, discuss the best ways to navigate patient return to care during COVID-19, USPSTF guidelines for universal Hepatitis C screening and identify groups at higher risk for HCV.

At the conclusion of this program, participants will be able to:

  • Discuss the best ways to navigate patient return to care during COVID-19
  • Explain the importance of following USPSTF guidelines for universal Hepatitis C screening 
  • Identify cross-generational groups considered to be at higher risk for HCV

ASCLS P.A.C.E.® credits are available to laboratory professionals through February 28, 2021.

Authors:

Becker, William J., DO, MPH
Clinical Pathology Medical Director
Quest Diagnostics, Lenexa, Kansas 

Rothrock, Weston H., MD
Associate Medical Director, Tampa, Florida
Laboratory Medical Director, Rapid Response Laboratories
Jacksonville, Leesburg, Largo, Florida 

 

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA certified laboratories that provide HIPAA covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA covered services. 

 

Quest, Quest Diagnostics, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2023 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.